Patent · US Active

Formulation for soft anticholinergic analogs

US11026919B2 · kind B2 · utility

3Cited by

15References

20Claims

0Family size

Assignee

BODOR LABORATORIES, INC. · US

Inventors

Nicholas S. Bodor · Surfside, US
John J. Koleng · Austin, US
David Angulo · Miami, US

Key dates

Filing date	Nov 30, 2020
Grant date	Jun 8, 2021
Priority date	—
Expiry date	Nov 30, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D207/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.